Literature DB >> 8944571

Increased gall bladder volume in primary sclerosing cholangitis.

P C van de Meeberg1, P Portincasa, F H Wolfhagen, K J van Erpecum, G P VanBerge-Henegouwen.   

Abstract

BACKGROUND: The diagnosis of primary sclerosing cholangitis (PSC) requires invasive procedures such as liver biopsy and endoscopic retrograde cholangiography (ERC). Sonographic measurement of fasting gall bladder volume, which has been reported to be enlarged in PSC, could serve as a non-invasive screening test.
METHODS: Fasting gall bladder volume was studied in patients with PSC (n = 24), primary biliary cirrhosis (PBC, n = 13), liver cirrhosis due to other causes (n = 18), ulcerative colitis (n = 15), and healthy controls (n = 23). Meal induced gall bladder emptying was studied in patients with PSC, patients with PBC, and healthy controls.
RESULTS: In patients with PSC gall bladder volume was greatly enlarged (72.9 (SEM 3.7) ml) compared with healthy controls (25.4 (1.7) ml, and patients with PBC (30.9 (2.7) ml), liver cirrhosis (31.3 (4.0) ml) or ulcerative colitis (25.8 (2.0) ml) (p < 0.0005 v all). In four patients with PSC the gall bladder wall was irregularly thickened (> 4 mm) as previously described in PSC. Postprandial residual fractions (% of fasting volume) were comparable between patients with PSC (17.5 (3.7)%) and those with PBC (23.6 (7.1%) and healthy controls (12.7 (2.3)%) Although gall bladder emptying seems normal, increased biliary pressure in patients with PSC cannot be excluded.
CONCLUSION: Apart from wall thickening, patients with PSC often present with enlargement of the gall bladder. Sonographic determination of fasting gall bladder volume may be a useful, non-invasive, and easy to perform tool in the evaluation of patients suspected of having PSC.

Entities:  

Mesh:

Year:  1996        PMID: 8944571      PMCID: PMC1383275          DOI: 10.1136/gut.39.4.594

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  30 in total

1.  Gallbladder volume and contraction measured by sum-of-cylinders method compared with ellipsoid and area-length methods.

Authors:  M F Stolk; K J van Erpecum; G P van Berge Henegouwen; O F Kesselring; W P Hopman
Journal:  Acta Radiol       Date:  1990-11       Impact factor: 1.990

Review 2.  The syndrome of primary sclerosing cholangitis.

Authors:  J Ludwig; N F LaRusso; R H Wiesner
Journal:  Prog Liver Dis       Date:  1990

3.  Effects of ursodeoxycholic acid on gallbladder contraction and cholecystokinin release in gallstone patients and normal subjects.

Authors:  K J van Erpecum; G P van Berge Henegouwen; M F Stolk; W P Hopman; J B Jansen; C B Lamers
Journal:  Gastroenterology       Date:  1990-09       Impact factor: 22.682

4.  Gallbladder volume in adults, and relationship to age, sex, body mass index, and gallstones: a sonographic population study.

Authors:  G Palasciano; G Serio; P Portincasa; V Palmieri; M Fanelli; A Velardi; B Calo' Gabrieli; V Vinciguerra
Journal:  Am J Gastroenterol       Date:  1992-04       Impact factor: 10.864

5.  Gallbladder motor function in obese versus lean females.

Authors:  C Kucio; P Besser; K Jonderko
Journal:  Eur J Clin Nutr       Date:  1988-02       Impact factor: 4.016

6.  Pancreatic ductal morphology and exocrine function in primary sclerosing cholangitis.

Authors:  E Lindström; G Bodemar; B O Rydén; I Ihse
Journal:  Acta Chir Scand       Date:  1990 Jun-Jul

7.  Postprandial gallbladder motility and plasma cholecystokinin at regular time intervals after injection of octreotide in acromegalics on long-term treatment.

Authors:  W P Hopman; P A Van Liessum; G F Pieters; J B Jansen; C B Lamers; A G Smals; G Rosenbusch; P W Kloppenborg
Journal:  Dig Dis Sci       Date:  1992-11       Impact factor: 3.199

8.  Opposite effects of cholestyramine and loxiglumide on gallbladder dynamics in humans.

Authors:  G Palasciano; P Portincasa; A Belfiore; G Baldassarre; O Albano
Journal:  Gastroenterology       Date:  1992-02       Impact factor: 22.682

9.  Fasting gallbladder volume, postprandial emptying and cholecystokinin release in gallstone patients and normal subjects.

Authors:  K J van Erpecum; G P van Berge Henegouwen; M F Stolk; W P Hopman; J B Jansen; C B Lamers
Journal:  J Hepatol       Date:  1992-03       Impact factor: 25.083

10.  Ursodeoxycholic acid for treatment of primary sclerosing cholangitis: a placebo-controlled trial.

Authors:  U Beuers; U Spengler; W Kruis; U Aydemir; B Wiebecke; W Heldwein; M Weinzierl; G R Pape; T Sauerbruch; G Paumgartner
Journal:  Hepatology       Date:  1992-09       Impact factor: 17.425

View more
  9 in total

Review 1.  Primary sclerosing cholangitis: updates in diagnosis and therapy.

Authors:  Piero Portincasa; Michele Vacca; Antonio Moschetta; Michele Petruzzelli; Giuseppe Palasciano; Karel J van Erpecum; Gerard P van Berge-Henegouwen
Journal:  World J Gastroenterol       Date:  2005-01-07       Impact factor: 5.742

Review 2.  Primary sclerosing cholangitis--approach to diagnosis.

Authors:  Ian L Steele; Cynthia Levy; Keith D Lindor
Journal:  MedGenMed       Date:  2007-04-25

Review 3.  Primary sclerosing cholangitis: review for radiologists.

Authors:  Matthew A Morgan; Rachita Khot; Karthik M Sundaram; Daniel R Ludwig; Rashmi T Nair; Pardeep K Mittal; Dhakshina M Ganeshan; Sudhakar K Venkatesh
Journal:  Abdom Radiol (NY)       Date:  2022-09-05

4.  Assessment of Three-Phasic CT Scan Findings of Cirrhosis Due to Primary Sclerosing Cholangitis Versus Cryptogenic Cirrhosis.

Authors:  Nazanin Sadraei; Hamed Jafari; Amin Sadraee; Banafsheh Zeinali-Rafsanjani; Hemmatollah Rastgooyan; Aryan Zahergivar
Journal:  Cureus       Date:  2022-04-08

5.  Intestinal absorption of the bile acid analogue 75Se-homocholic acid-taurine is increased in primary biliary cirrhosis, and reverts to normal during ursodeoxycholic acid administration.

Authors:  A Lanzini; M G De Tavonatti; B Panarotto; S Scalia; A Mora; F Benini; O Baisini; F Lanzarotto
Journal:  Gut       Date:  2003-09       Impact factor: 23.059

6.  Gallbladder emptying in patients with primary sclerosing cholangitis.

Authors:  Karouk Said; Nick Edsborg; Nils Albiin; Annika Bergquist
Journal:  World J Gastroenterol       Date:  2009-07-28       Impact factor: 5.742

7.  Impaired gallbladder motility and delayed orocecal transit contribute to pigment gallstone and biliary sludge formation in beta-thalassemia major adults.

Authors:  Piero Portincasa; Antonio Moschetta; Massimo Berardino; Agostino Di-Ciaula; Michele Vacca; Giuseppe Baldassarre; Anna Pietrapertosa; Rosario Cammarota; Nunzia Tannoia; Giuseppe Palasciano
Journal:  World J Gastroenterol       Date:  2004-08-15       Impact factor: 5.742

Review 8.  A Review of the Challenges Associated with the Diagnosis and Therapy of Primary Sclerosing Cholangitis.

Authors:  Mohammed Saadi; Christine Yu; Mohamed O Othman
Journal:  J Clin Transl Hepatol       Date:  2014-03-15

9.  A Quantitative Magnetic Resonance Cholangiopancreatography Metric of Intrahepatic Biliary Dilatation Severity Detects High-Risk Primary Sclerosing Cholangitis.

Authors:  Emmanuel A Selvaraj; Ahmed Ba-Ssalamah; Sarah Poetter-Lang; Gerard R Ridgway; J Michael Brady; Jane Collier; Emma L Culver; Adam Bailey; Michael Pavlides
Journal:  Hepatol Commun       Date:  2021-11-21
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.